Artelo Biosciences (ARTL) Change in Acquisitions & Divestments (2021 - 2024)

Artelo Biosciences (ARTL) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $500000.0 the latest figure, recorded in Q4 2024.

• In Q4 2024, Change in Acquisitions & Divestments fell 86.45% year-over-year to $500000.0; the TTM figure through Sep 2025 stood at $500000.0 (down 95.63% YoY), while the FY2024 annual figure was $8.2 million, down 47.39% from the prior year.
• Change in Acquisitions & Divestments fell to $500000.0 in Q4 2024 per ARTL's latest filing, from $4.2 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $6.5 million in Q1 2023 and bottomed at -$11.2 million in Q4 2022.
• Historically, Change in Acquisitions & Divestments has averaged $2.0 million across 4 years, with a median of $2.8 million in 2023.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments jumped 140.1% — and 2024, when it tumbled 86.45%.
• Artelo Biosciences' Change in Acquisitions & Divestments stood at $1.9 million in 2021, then sank by 693.24% to -$11.2 million in 2022, then soared by 133.09% to $3.7 million in 2023, then sank by 86.45% to $500000.0 in 2024.
• Business Quant data shows ARTL's Change in Acquisitions & Divestments at $500000.0 in Q4 2024, $4.2 million in Q3 2024, and $1.8 million in Q2 2024.